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Background: Most recent studies of Clostridium perfringens plasmids have focused on toxin-encoding or antibiotic
resistance plasmids. To cause intestinal disease, a toxigenic strain must grow in the intestines to levels allowing for
sufficient toxin production and this in vivo growth often involves overcoming the normal intestinal microbial population.
For this purpose, bacteriocin production might be important.
Results: In this study, as the first step in the genetic analysis of a co-existing plasmid with an enterotoxin gene
(cpe)-encoding plasmid, the bacteriocin gene-encoding plasmid, pBCNF5603, was completely sequenced. This plasmid
has some homology with two previously sequenced C. perfringens plasmids, namely, pCP13 carrying a cpb2 gene and
pIP404 carrying a bcn gene. Using recombinant plasmids, the rep gene homologous to the PCP63 gene on pCP13
appeared to be functional. Comparative genomics indicated that the identified rep gene homologs were found on
two additional toxin plasmids, pCP-OS1 and pCP-TS1. While functional analysis using recombinant plasmids indicated
that pBCNF5603 and pCP13 are likely to be incompatible, the plasmid replication and partitioning region of pBCNF5603
alone was insufficient for stable maintenance of this plasmid.
Conclusions: These findings suggest that pBCNF5603 evolved from recombination events between C. perfringens
plasmids and inter-species mobile genetic element(s). In addition, the bcn-encoding plasmid, pBCNF5603, is likely to be
included in the Inc family, which includes pCP13 and two variant iota-encoding plasmids. Furthermore, the bcn gene
on pBCNF5603 could contribute to gastrointestinal disease induced by enterotoxigenic C. perfringens.
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Clostridium perfringens is an important Gram-positive
pathogen, but also a member of the normal gastrointes-
tinal flora of humans and animals [1]. The pathogenicity
of this bacterium to humans and livestock largely de-
pends upon toxin production, with 16 different C. per-
fringens toxins reported in the literature [1]. Most C.
perfringens toxin genes, including three typing toxin
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C. perfringens large cytotoxin gene (tepL), are present on
plasmids [2-4]. Therefore, the presence of toxin gene-
encoding plasmids is crucial for C. perfringens virulence.
For C. perfringens strains producing C. perfringens en-
terotoxin (CPE) to cause non-foodborne human intes-
tinal disease, they not only have to produce toxins, but
also must overcome the normal microbial population so
they can grow to pathogenic levels [5]. For this purpose,
the production of bacteriocins might be useful [5]. Previ-
ous surveys of bacteriocins support this possibility since
studies conducted in the 1960s and 1970s showed that
many C. perfringens isolates produce bacteriocins [6].tral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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much less attention recently than the toxins which induce
the diseases caused by this bacterium, such as human and
veterinary diarrhea.
On a completely sequenced cpe-encoding plasmid,
pCPF5603, in the enterotoxigenic F5603 strain, which was
isolated from a patient suffering from non-foodborne diar-
rheal disease, the gene encoding a bacteriocin that con-
tributes to C. perfringens virulence was not identified.
Therefore, an unidentified virulence factor such as a bac-
teriocin could be encoded on another co-existing plasmid.
In this study, the plasmid carrying a bacteriocin gene
(bcn) homolog in the enterotoxigenic F5603 strain was
completely sequenced. Thereafter, to understand the rela-
tionships with the co-existing prototype of toxin-encoding
plasmid or other type(s) of toxin plasmid such as pCP13,
the replication region of bcn-encoding plasmid was identi-
fied. Then, the replication region on pBCNF5603 was com-
pared with those of other sequenced plasmids by
comparative genomics because the replication region,
which must contain the replication initiation protein (Rep)
gene (rep), is a basic element of a plasmid [7]. Moreover,
the identified replication and putative partitioning region
was functionally investigated.
Methods
Bacterial strains and media
Clostridium perfringens strains F5603, NCTC8533,
ATCC3624, and strain 13 were used in this study [8-10].
For the growth of these strains, TGY medium (3 % tryptic
soy broth [TSB] [BD Bioscience, Tokyo, Japan], 2 % glu-
cose, 1 % yeast extract [BD Bioscience, Tokyo, Japan], and
0.1 % L-cysteine [Wako Pure Chemical, Osaka, Japan])
with or without chloramphenicol (10 μg/ml) (Wako Pure
Chemical, Osaka, Japan) was used as previously described
[8, 9]. E. coli HB101 was used as the host for the recombin-
ant plasmids used for DNA sequencing or for constructing
recombinant plasmids carrying the putative replication re-
gion from C. perfringens plasmids. For the selection of E.
coli or C. perfringens transformants, TSB agar containing
ampicillin (100 μg/ml) (Wako Pure Chemical, Osaka,
Japan) or chloramphenicol (30 μg/ml) and Brain Heart
Infusion (BHI) (BD Bioscience, Tokyo, Japan) agar with
chloramphenicol (15 μg/ml) were used, respectively.
Complete sequencing of the bacteriocin-encoding plasmid
pBCNF5603 in F5603 and plasmid pCP8533S12 carrying a
pIP404-rep homolog in NCTC8533
Sequencing of a bacteriocin-encoding plasmid in strain
F5603 was performed using a previously described
method [8]. Briefly, crude plasmid DNA preparations were
prepared as described previously [8] and then transfor-
mants carrying F5603 plasmid DNA fragments, which
were not from the completely sequenced cpe-encodingplasmid pCPF5603, were selected and then sequenced. To
complete the sequencing of pBCNF5603, long-range PCR
analysis was performed using primers based upon end-
sequence information. Those PCR products were then se-
quenced using a primer walking strategy.
For sequencing of a small plasmid named pCP8533S12,
which is present in type B strain NCTC8533 and carries a
pIP404 rep homolog, PCR primers were constructed based
on the sequence of a small plasmid in ATCC3626, another
type B strain (accession number: NZ_ABDV01000054).
The PCR products obtained using those primers were
then used for direct sequencing.
Putative ORFs on both sequenced plasmids were pre-
dicted with ORF finder software (http://www.ncbi.nml.nih.
gov/gorf/gorf.html) and a putative Shine-Dalgarno se-
quence for each ORF was identified. Annotation of each
ORF was predicted with BLAST blast.ncbi.nlm.nih.gov/
Blast.egi web database software.Identification of the replication region in the bacteriocin-
encoding plasmid pBCNF5603
Sequence analysis with BLAST indicated that pBCNF5603
mainly consists of two regions: a pCP13-like ORF region
and a pIP404-like bacteriocin region (described in the re-
sults section). In addition, each region of pBCNF5603 was
shown to harbor putative replication regions, namely, the
PBCN16-18 region homologous to the PCP63-parA (soj)-
parB (spo0J) gene cluster on pCP13 and the PBCN29-30
region homologous to the cop-rep region of pIP404. To
investigate the replication ability of these two putative rep-
lication regions, each one was separately amplified by
PCR. The primers used for amplification of the putative
replication regions are listed in Additional file 1: Table S1.
In these PCR reactions, each PCR mixture contained 1 μl
of template DNA, 0.4 μl of GXL Taq polymerase
(TAKARA BIO, Otsu, Japan), 3 μl of 2 mM NTPs, 10 μl
of PCR buffer, and 2 μl of each primer pair (1 μM final
concentration). PCR reactions were performed under con-
ditions previously described [11]. After confirming PCR
amplification, each PCR product was clarified using the
QIAquick PCR purification kit (QIAGEN, Tokyo, Japan)
and then digested with restriction enzymes: AvrII/BstBI
(NEB, Tokyo, Japan) or AvrII/HpaI (NEB, Tokyo, Japan)
for the pCP13-homologous putative replication region on
pBCNF5603; SpeI/SnaBI (NEB, Tokyo, Japan) for the
pIP404-homologous putative replication region on
pBCNF5603; and BsmI/PflMI (NEB, Tokyo, Japan) for the
putative rep region on pCP8533S12 (Fig. 2). Digested DNA
fragments were subjected to filling with Klenow fragment
polymerase (Promega, Tokyo, Japan), and were ligated into
a fragment of shuttle vector pJIR750, in which the rep gene
of pIP404 had been removed by digestion with XmnI
(NEB, Tokyo, Japan) and SpeI (NEB, Tokyo, Japan) [12].
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pKZ200, or pKZ210, were transformed into E. coli
HB101 and then electroporated into transformable C.
perfringens type A strains, ATCC3624 and strain 13,
using Electro Cell Manipulator, ECM630 (BTX), accord-
ing to the manufacturer’s instructions (Table 1) [13].
Briefly, 0.6 ml of overnight TGY culture of C. perfringens
strain was inoculated into 20 ml of TGY medium and
anaerobically incubated at 37 °C for 6 to 8 h. Bacterial
cells were collected by centrifugation at 3,000 x g for 20
min. Collected cells were washed twice with SMP solu-
tion (270 mM sucrose [Pure Chemical, Osaka, Japan], 1
mM MgCl2 [Pure Chemical, Osaka, Japan] in 7 mM so-
dium phosphate solution, pH7.4) and then centrifuged.
The washed bacterial pellet was re-suspended with 1.2
ml of SMP solution. A 600 μl aliquot of re-suspended
cells was used for electroporation. Transformants carry-
ing a recombinant plasmid were selected on BHI agar
plates containing 15 μg/ml chloramphenicol.
Compatibility assay between recombinant plasmids
derived from pBCNF5603 and pCP13
From the results of comparative genomics, the identified
rep gene was highly similar to PCP63 (probable rep gene
on pCP13) in strain 13. To understand the relationship be-
tween pBCNF5603 and pCP13, compatibility assay was per-
formed. The constructed recombinant plasmid (pKZ200 or
pKZ210) carrying the rep gene of pBCNF5603 was intro-
duced into strain 13 according to the electroporation
methods previously described [13]. In the final step of the
electroporation procedures, electroporated samples were
inoculated into 4 ml of pre-warmed TGY medium without
antibiotics. After 3-h incubation at 37 °C, 0.2 ml of a 4 ml
transformed culture sample was inoculated into 10 ml of
TGY medium with chloramphenicol (10 mg/ml) and incu-
bated at 37 °C. The next day, 0.2 ml of culture sample was
inoculated in fresh TGY medium with chloramphenicol
and incubated at 37 °C (passage 2). One-day culture of this
second-passage sample was spread onto a BHI agar plate
containing 15 mg/ml chloramphenicol, which was then an-
aerobically incubated at 37 °C.
To investigate the presence or absence of pCP13 in
transformed C. perfringens colonies, randomly selected
chloramphenicol-resistant colonies were tested by col-
ony PCR assay for three genes: cpb2 (the β2 toxin gene),Table 1 Plasmids constructed and used in this study
Plasmid
pJIR750 HindIII/EcoRV (2629 bp) fragment o
pKZ100 pJIR750 (XmnI/SpeI) Ω pBCNF5603
pKZ110 pJIR750 (XmnI/SpeI) Ω pCP8533S12
pKZ200 pJIR750 (XmnI/SpeI) Ω pBCNF5603
pKZ210 pJIR750 (XmnI/SpeI) Ω pBCNF5603topA (the gene of topoisomerase homolog), and cna (a
putative collagen adhesion protein gene), on pCP13. For
colony PCR reaction, colonies were suspended in 20 μl
of distilled water and then heated at 100 °C for 10 min.
After brief centrifugation, 1 μl of supernatant was used
as a DNA template with PCR reaction. Each PCR mix-
ture (50 μl) contained 1 μl of template DNA, 0.25 μl of
EX Taq polymerase (TAKARA BIO, Otsu, Japan), 4 μl of
2.5 mM NTPs, 5 μl of PCR buffer, and 2 μl of each pri-
mer pair (1 μM final concentration). PCR reactions were
performed under the following conditions: 95 °C, for 2
min; 35 cycles of 95 °C for 30 sec, 61 °C (for cpb2, cna)
or 64 °C (for topA) for 30 sec, and 72 °C for 30 sec; and
a single extension at 72 °C for 5 min. PCR products were
electrophoresed on a 1.5 % agarose gel followed by stain-
ing with UltraPower™ DNA Stain (Gellex, Tokyo, Japan),
and then fluorescence was detected using LAS-4000
(FUJIFILM).
The stability of the constructed recombinant plasmid in
two type A C. perfringens strains
Upstream of the rep gene, pBCNF5603 is also assumed
to harbor the conserved plasmid partitioning region, in-
cluding parA and parB genes and putative parS se-
quences. To investigate the contribution of putative
plasmid partitioning regions to plasmid stability, the sta-
bility of a recombinant plasmid, pKZ200, which carries
the replication and putative partitioning region, was esti-
mated (Fig. 2). First, the recombinant plasmid was intro-
duced into two transformable C. perfringens strains:
ATCC3624 and strain 13. The type A ATCC3624 strain
is likely to carry no plasmid, but strain 13 harbors pCP13,
which carries a replication and partitioning region homolo-
gous to that of pBCNF5603, as described in the results sec-
tion. Therefore, to estimate the stability of pKZ200 in
strain 13, two chloramphenicol-resistant pCP13-free clones
of strain 13-derived transformants were selected using
the compatibility assay described above, and then used
for plasmid stability assay; specifically, two clones of
ATCC3624-derived transformants and two clones of
pCP13-free strain 13 transformants were used.
Each of the stocked clones in cooked meat medium was
inoculated into 10 ml of FTG medium (BD Bioscience,
Tokyo, Japan) and incubated at 37 °C. Overnight cultures
were then inoculated into 10 ml of TGY medium, incubatedf pIP404 replication region
PCR product (SpeI/SnaBI; 3120 bp) (cop and rep fragment)
PCR product (BsmI/PflMI; 2632 bp) (rep fragment)
PCR product (AvrII/BstBI; 5476 bp) (PCP63, soj, parB and PCP03 fragment)
PCR product (AvrII/HpaI; 2271 bp) (PCP63 fragment)
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phenicol (15 mg/ml), and then anaerobically incubated at
37 °C. To estimate the stability of the recombinant plas-
mid, pKZ200, in C. perfringens strains, two separate col-
onies of each clone were inoculated into 10 ml of TGY
medium cotaining chloramphenicol (10 μg/ml) and incu-
bated at 37 °C. Then, 0.2 ml of overnight culture was inoc-
ulated into 10 ml of fresh TGY medium containing
chloramphenicol. After incubation for 24 h at 37 °C, a 10
μl culture sample was transferred to 10 ml of fresh TGY
without chloramphenicol, so that approximately 10 gener-
ations were obtained per growth cycle of 24 h (1:210 dilu-
tion rate) [14]. These inoculated cultures were used as a
first passage. Every 24 h, 10 μl of the full-grown cultures
was transferred to 10 ml of fresh TGY. After 6 passages,
the cultures were diluted and plated on a BHI plate with-
out chloramphenicol. Determination of the fraction of re-
combinant plasmid cured cells in the population was
performed by replica-picking of 25 randomly chosen
colonies onto BHI with chloramphenicol (15 μg/ml)
and without chloramphenicol, and scoring the
chloramphenicol-sensitive colonies. To confirm the
presence or absence of pKZ200, eight chloramphenicol-
sensitive and eight chloramphenicol-resistant colonies
were tested by colony PCR assay for the rep gene. In-
compatibility between pKZ200 and indigenous pCP13
must influence the stability of the recombinant plasmid.
To avoid the possibility of contamination with original














































































































Fig. 1 Genetic organization of predicted ORFs on pBCNF5603. Above the l
line, it is the opposite. Green boxes depict the ORFs homologous to that o
Sequences of pCP13 and pIP404 have been reported previously [15, 16]Results
Organization of the bcn5603-encoding plasmid
pBCNF5603 in F5603
In a previous study with pulsed-field gel electrophoresis
(PFGE) analysis, C. perfringens F5603 strain carried two
large plasmids, ~75 kb cpe-encoding plasmid and an-
other ~40 kb plasmid [8] (Additional file 2: Figure S1).
Sequencing revealed that pBCNF5603 (GenBank acces-
sion no. AB189671) is 36,695 bp in size, with 25.4 % GC
content and encoding 36 ORFs. The size of sequenced
plasmid closely agreed with the predicted size of a
smaller ~40 kb plasmid in F5603 strain in PFGE analysis.
In comparison with the sequences of pCP13 and pIP404,
pBCNF5603 carries 15 or 8 ORFs that are highly hom-
ologous to ORFs present on pCP13 and pIP404, respect-
ively [10, 15] (Fig. 1) (Additional file 1: Table S2). Of the
fourteen pCP13 ORF homologs on pBCNF5603, a gene
cluster from PBCN8 to PBCN15 was similarly arranged
from PCP34 to PCP44, and a gene cluster from PBCN16
to PBCN19 was also from PCP63 to PCP03 (Fig. 1)
(Additional file 1: Table S2) [10]. In the gene cluster
from PBCN16 to PBCN19, pBCNF5603 carries parA and
parB genes, which are highly homologous to the respect-
ive genes on pCP13, but which are absent from pIP404
[10, 15]. Therefore, this region might contain the genes
for plasmid replication and maintenance, while the repli-
cation system of pCP13 has not yet been identified [10].
In eight shared ORFs with pIP404, pBCNF5603 en-
codes the putative bacteriocin BCN5603 gene (bcn5603)
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gene (bcn) was originally found in the type A human iso-
late CPN50. In comparative genomics, the product of
the bcn5603 gene, BCN5603, showed similarity to the
gene products in C. perfringens strains: food poisoning
strain-derived SM101, type E JGS1987, type C JGS1495,
and type D JGS1721 strains, in addition to CPN50 strain.
These bacteriocins in the virulent C. perfringens strain
shared conserved domains: two SH3b domains (usually
found on bacteriocins) and peptidase M14 superfamily
domain, which contained two Zn-binding sites. In
addition to these conserved domains on putative bacte-
riocins, BCN5603 carried putative cell wall binding re-
peat, and two glucan-binding repeats (Glucan65).
Of the bacteriocins in C. perfringens, the regulation of
BCN5 production has been investigated most inten-
sively; BCN5 is induced by an SOS response to UV light
or mitomycin C treatment [16, 17]. Of the putative bac-
teriocin regulatory genes, the putative uviA gene on
pBCNF5603 has 98.9 % nucleotide sequence homology
with the uviA gene, which is the putative sigma factor for
the bcn5 gene on pIP404. In addition, on the basis of
amino acid substitution of the uviA genes on both plas-
mids, regions 4.2 and 2.4 of the UviA sigma factor, which
are implicated in interactions with the −35 and −10
sequence of the promoter, were completely identical [16].
The uviB gene on pBCNF5603 had a completely identical
nucleotide sequence with the uviB gene, which is the pu-
tative bacteriocin immunity-related gene on pIP404 [16].
Moreover, the bcn5603-uviA-uviB gene cluster had three
promoter sequences almost identical to those in the ori-
ginal bcn gene region on pIP404. Specifically, compared
with the matching promoter sequences of BCN5 [17], the
bcn5603 gene has two putative promoter sequences: P1
(the strongest promoter of the bcn gene on pIP404) and
P2, which are completely identical, as well as P3 with only
one nucleotide change. Therefore, the bcn5603 gene
might be dependent on UviA for activation. Furthermore,
the P4 and P5 promoters upstream of the uviA gene on
pBCNF5603 had identical sequences to those on pIP404,
and the putative repressor LexA-binding site of the
bcn5603 gene also had an identical sequence with the cor-
responding site in the pIP404 BCN5 regulatory region
[17]. From these highly similar sequences in the regulatory
region, the enterotoxigenic strain F5603 might produce
BCN5603 in a similar manner to BCN5 by strain CNP50.
pBCNF5603 also carries a cluster of five ORFs (putatively
encoding a sensor histidine kinase, response regulator,
ATPase, and two permease genes) with high homology to
respective genes present on the chromosome of E. faecalis
V583 and the S. agalactiae 2603V/R strain [18, 19] (Fig. 1)
(Additional file 1: Table S2).
Overall, pBCNF5603 was identified as a bacteriocin-
encoding plasmid that developed from a mosaic fusionof C. perfringens plasmids, cpb2-encoding pCP13 and
bcn-encoding pIP404, and a foreign gene cluster.
Identification of the replication region of pBCNF5603
Completely sequenced pBCNF5603 is likely to be an im-
portant plasmid for C. perfringens virulence because this
plasmid encodes a bacteriocin gene. Moreover, pBCNF5603
co-exists with one of the prototype cpe-encoding plas-
mids, pCPF5603. Therefore, to investigate further the bac-
teriocin gene-encoding plasmid, the replication region of
pBCNF5603 was initially identified in the current study.
Sequencing and comparative genomics showed that
pBCNF5603 carried two sets of potential plasmid replica-
tion regions, namely, the region containing putative plas-
mid partitioning genes, parA and parB, which was similar
to that region on pCP13 (Fig. 1), and putative rep and cop
genes similar to the replication region of pIP404.
It was initially shown that a recombinant plasmid named
pKZ200 carrying a ~5.5 kb fragment including the PBCN16
(PCP63 homolog)-parA-parB-PBCN19 (PCP03 homolog)
gene cluster could replicate in C. perfringens strains,
ATCC3624 and strain 13 (Fig. 2a, Table 1). The recombin-
ant plasmid that still supported plasmid replication in two
strains was pKZ210, carrying a smaller ~2.3 kb region
containing PBCN16, and its upstream region (including the
partial parA ORF) (Fig. 2a, Table 1). These results indicate
that PBCN16, the product of which is a homolog of
the PCP63 product, was likely to be the rep gene of
pBCNF5603. The upstream region of the identified rep
gene, five distinct pairs of 6 to 8 bp inverted repeats (IRs),
which could act as iteron-like sequences in the initiation of
pBCNF5603 replication, and an AT-rich region, which is
also important for plasmid replication, were identified
(Fig. 3) [7]. Therefore, pBCNF5603 was identified as one of
the iteron-containing plasmids (ICP) in C. perfringens.
Concerning the replication ability of the second region,
ATCC3624 strain carrying the constructed plasmid named
pKZ100, which carried the putative cop-rep region similar
to the replication region of pIP404, was not detected in sev-
eral electroporation experiments (Table 1, Fig. 2b). On the
other hand, a constructed plasmid named pKZ110 carrying
the ~2.6 kb region containing the putative rep gene of
pCP8533S12 could replicate in the ATCC3624 strain
(Table 1, Fig. 2b).
Collectively, only the region containing genes similar
to the genes on pCP13 was identified as a region carry-
ing the newly identified rep gene, while two potential
replication (and maintenance) regions were identified on
pBCNF5603 by comparative genomics.
Comparative genomic analysis of the genes in the
identified replication region
By comparative genomics using the GenBank database,










































Fig. 2 a Schematic comparison of the newly identified replication and partitioning region on: I) C. perfringens plasmid pBCNF5603 of F5603, II) C.
perfringens plasmid pCP13 of strain 13, or III) C. perfringens plasmid pCP8533cpb of NCTC8533. The yellow boxes show ORFs on the putative rep
gene, and blue boxes show conserved genes in the putative partitioning region; the smallest boxes show the region of a putative parS sequence.
HP depicts the genes encoding a hypothetical protein, and CHP depicts the gene encoding a conserved hypothetical protein. Shaded bars show
the region inserted in pKZ200 (upper bar) or pKZ210 (lower bar). b Schematic comparison of the putative replication region on: I) C. perfringens
plasmid pBCNF5603 of F5603, II) C. perfringens plasmid pCP8533S12 of NCTC8533. The yellow boxes show the putative rep genes, and orange box
shows a putative deleted region of a putative rep gene on pBCNF5603, which is homologous to the rep gene on pIP404 or on pCP8533S12, or III)
C. perfringens plasmid pIP404 of CPN50
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on pCP13 (accession number: AP003515), four other
homologous genes were found, namely, a gene on pCP-
OS1 (accession number: AP013033), a gene on pCP-TS1
(accession number: AP013034) (these two plasmids har-
bor the recently identified iota toxin gene variants), a
gene on pF262B (accession number: AFES01000051),
and a gene on a plasmid in the WAL-14572 strain (ac-
cession number: ADLP01000024) [20, 21] (Table 2).
These genes encode hypothetical proteins. Of these
genes, PCP63 (651 bp) on pCP13 was the smallest; the
rep gene on pBCNF5603 was 852 bp long, and the hom-
ologous genes on pCP-TS1 or pCP-OS1 and those of
pF262B or plasmid in WAL-14572 were 918 bp and 906
bp, respectively. In the upstream region, each of the pu-
tative rep genes on the four plasmids carried iteron-like
sequences that were highly similar to those of the rep
gene of pBCNF5603, while the putative iteron sequences
were not identified in the upstream region of PCP63
(Fig. 3). Moreover, pBCNF5603 and pCP13 in strain 13
from our laboratory stocks were likely to be incompat-
ible (described in the results section). Therefore, for fur-
ther comparison of those homologs, sequencing analysis
of the putative replication region of pCP13 in strain 13in our laboratory stocks was performed. In terms of the
sequencing results of the PCP63 region in strain 13 from
our laboratory stocks, PCP63 was 906 bp long and also
harbored highly similar iteron-like sequences with a pu-
tative rep gene on other plasmids (accession number:
LC011526) (Fig. 3, Table 2).
Collectively, bacteriocin- or toxin-encoding plasmids
harbor the rep gene homologous to that of pBCNF5603;
the plasmid group carrying the pBCNF5603-type rep
gene is likely to contribute to C. perfringens virulence.
Sequencing also showed that pBCNF5603 carries sev-
eral gene homologs that appear to be involved in the
replication and maintenance systems of pIP404 [15]. The
replication system of pIP404 is similar to the Inc18 family
of plasmids, whose replication system consists of cop-rep-
ori-res genes [15]. Of these four replication component
genes, pBCNF5603 was found to carry two ORFs, namely,
PBCN29 and PBCN30, which are highly similar to pIP404
genes that are thought to encode putative plasmid stability
and replication factors, respectively [15]. Therefore, a can-
didate Rep protein of pBCNF5603 is probably encoded by
PBCN30, which is homologous (92 % identity) to the rep
gene (ORF5) of pIP404 (Additional file 1: Table S1). How-
ever, PBCN30, which is ~1,000 bp in size, is smaller than
Table 2 Similarity of the genes on the replication and partitioning region among C. perfringens plasmids carrying PCP63 homolog
PCP63 homologs parA (soj) parB parS sequence PCP03 homologs
ORF size Identitya ORF size Identitya ORF size Identitya length ORF size Identitya
pBCNF5603 852 bp 100 % 753 bp 100 % 1278 bp 100 % 117 bp 363 bp 100 %
pCP13 906 bp 92 % 753 bp 99 % 1281 bp 96 % 117 bp 363 bp 94 %
pCP-TS1 918 bp 91 % 753 bp 97 % 1281 bp 99 % 117 bp 363 bp 90 %
pCP-OS1 918 bp 90 % 753 bp 97 % 1281 bp 99 % 117 bp 363 bp 90 %
pF262B 906 bp 93 % 753 bp 99 % 1278 bp 100 % 117 bp 363 bp 99 %
pWAL-14572 906 bp 93 % 753 bp 99 % 1278 bp 100 % 117 bp 363 bp 99 %
pCP8533cpb - - 753 bp 98 % 1281 bp 96 % 117 bp 363 bp 96 %
JGS1945cpb - - 753 bp 99 % 1281 bp 96 % 117 bp 363 bp 95 %








Fig. 3 Repeated elements in the upstream region of the identified rep genes on pBCNF5603 and of the PCP63 homologs of other plasmids. The
arrow-headed bars depict the five pairs of inverted repeats (IR1 to IR5). The rep gene ORF starts next to the final nucleotide
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bp in the 3’ region (Fig. 2b).
A putative rep gene, which is also similar to the rep gene
on pIP404, was also found on a small plasmid (~12 kb) in
type B strain NCTC8533 and named pCP8533S12 (acces-
sion number: AB736082, Additional file 1: Table S3)
(Fig. 2b). The size of this rep gene was similar to that of
the rep gene on pIP404, but larger than that of the
PBCN30 gene on pBCN5603. In the GenBank data-
base, homologous rep genes were found on a ~12 kb
plasmid in type B strain ATCC3626 (accession number:
ABDV01000054), on a ~13 kb plasmid in type C strain
JGS1945 (accession number: ABDU01000032), on a ~4 kb
plasmid in type D strain JGS1721 (accession number:
ABOO01000094), and on a ~12 kb bacteriocin-encoding
plasmid in type A enterotoxigenic SM101 strains (acces-
sion number: NC_008264). The length of these putative
rep genes was ~1,200 bp, while that of a pIP404-rep hom-
ologous gene (PBCN30) on pBCNF5603 was smaller than
other putative rep genes by ~1,000 bp, with truncation at
the 3’ end because of an insertion (deletion) producing a
stop codon at a later site. Interestingly, a ~1,000 bp se-
quence at the 5’ end of these putative rep genes was very
similar (percent identities of nucleotides among the rep
genes of more than 90 %; ranging from 91.4 to 98.0 %),
while ~200 bp sequences on the 3’ ends of these genes
were less conserved (percent identities of 57.9-84.7 %).
Compatibility between pCP13 and constructed recombinant
plasmids carrying the identified replication region
Each set of twenty-five chloramphenicol-resistant colonies
from second-passaged cultures of strain 13, which were
introduced by recombinant plasmids, pKZ210 (carrying
PCP63 homolog and its upstream region) or pKZ200 (car-
rying the parA and parB genes, and putative parS region),
were investigated (Fig. 2a). No chloramphenicol-resistant
colonies showed a positive reaction in the PCR assay for
the cpb2 gene, and these investigated colonies also showed
a negative reaction in the PCR assay for the topA gene or
the cna gene on pCP13; this was likely to have occurred to
cure the cpb2-encoding plasmid, pCP13, in strain 13-
derived colonies introduced by one of the recombinant
plasmids that carry the identified replication region with
or without a putative partitioning region.
Stability of the recombinant plasmid carrying the identified
replication region and a putative partitioning region
The putative partitioning region of pBCNF5603 contains
two genes, parA (a putative ATPase gene) and parB
(centromere-binding protein gene), and a putative parS
sequence (Fig. 2a). The parA and parB genes were found
on five other plasmids that harbor the identified rep
gene homolog, and those gene products had more than
96 % identity in terms of substituted amino acids(Table 2). A putative parS sequence contained IR1, IR2,
and one repeated sequence (Additional file 3: Figure S2),
and the sequences of the parS region were almost identi-
cal among six plasmids; that is, these plasmids are likely
to carry a similar plasmid replication and partitioning
region to that of pBCNF5603. These findings also indi-
cate that a putative partitioning system on these plas-
mids might be the parABS system.
To investigate the contribution of the putative partition-
ing system on pBCNF5603 to plasmid stability, the frac-
tion carrying the recombinant plasmid, pKZ200, was
monitored without any selection in two different C. per-
fringens hosts. In transformants derived from C. perfrin-
gens strains, ATCC3624 and strain 13, the proportion of
chloramphenicol-resistant colonies dropped to ~40 %
after 60 generations without antibiotic selection, while it
was more than 80 % under antibiotic pressure (Table 3).
Therefore, the recombinant plasmid was considered to be
unstable in both strains; all transformants from both
strains showed high plasmid loss in terms of the propor-
tion of plasmid-free cells. Moreover, there was no clear re-
lationship between the host strain type and the stability of
the recombinant plasmid, while strain 13 originally har-
bored an indigenous pCP13 that carries the closely related
replication and partioning region of pBCNF5603.
In contrast to the stability of the recombinant plasmid
in C. perfringens strains, an indigenous plasmid in the
original strain, pBCNF5603 in F5603 or pCP13 in strain
13, was extremely stable; after 60 generations, no indi-
genous plasmid-cured colonies were detected by PCR
assays for two genes: the rep and the bcn5603 or cpb2
genes, respectively (Table 3).
Discussion
Bacteriocins could contribute to diseases caused by C. per-
fringens, for example, promoting intestinal colonization
[5]. Of several identified C. perfringens bacteriocins, the
most investigated one is BCN5 in the type A cpe-negative
strain CPN50. BCN5 production is induced by stress, such
as UV irradiation, and its gene is encoded by the well-
studied plasmid pIP404, which has been completely se-
quenced and for which the gene for plasmid replication
was identified [15]. From the results in the current study,
a plasmid named pBCNF5603, which does not encode
toxins, was found to co-exist with the cpe/cpb2 toxin gene
encoding plasmid pCPF5603 in the enterotoxigenic type
A strain F5603. pBCNF5603 carries the putative bacteri-
ocin gene bcn5603 and its regulatory sequences, as deter-
mined from the results of complete sequence analysis
(Fig. 1) (Additional file 1: Table S2). Of all C. perfringens
bacteriocin genes, only the genetic background of the bac-
teriocin (BCN5) gene (bcn) found on pIP404 in the type A
CPN50 strain has been carefully investigated [16, 17]. The
same as the bcn gene on pIP404, the bcn5603 gene had
Table 3 Stability of a recombinant plasmid, pKZ200, and plasmids,
pBCNF5603 and pCP13, in C. perfringens strains
Incidence of colonies carrying a recombinant plasmid, pKZ200, in
ATCC3624 strain
Rate of Cp resistant colonies*
clone 1 Culture with Cp 92 %
Culture without Cp 40 %
clone 2 Culture with Cp 84 %
Culture without Cp 44 %
Incidence of colonies carrying a ecombinant plasmid, pKZ200, in strain
13
Rate of Cp resistant colonies*
clone 1 Culture with Cp 80 %
Culture without Cp 40 %
clone 2 Culture with Cp 96 %
Culture without Cp 44 %
Incidence of colonies carrying a bacteriosin gene (bcn5603)-encoding
plasmid, pBCNF5603, in F5603 strain
Rate of PCR positive colonies*, #
clone 1 PCR for the rep gene 100 %
PCR for the bcn5603 gene 100 %
clone 2 PCR for the rep gene 100 %
PCR for the bcn5603 gene 100 %
Incidence of colonies carrying the beta2 toxin gene-encoding plasmid,
pCP13, in strain 13
Rate of PCR positive colonies*, #
clone 1 PCR for the PCP63 gene 100 %
PCR for the cpb2 gene 100 %
clone 2 PCR for the PCP63 gene 100 %
PCR for the cpb2 gene 100 %
Culture samples with or without 10 µg/ml chloramphenicol were collected
after ~60 generations
*: Rate of randomly selected colonies
#: To investigate the presence of pBCNF5603 in F5603 strain or pCP13 in
strain13, randomly selected colonies were tested with colony PCR assay for
three genes, rep (PCP63), bcn5603, and cpb2 genes. Colony PCR reactions were
performed under the same conditions as described in the plasmid
compatibility section
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such as promoter sequences and the LexA-binding se-
quence. Moreover, these regulatory sequences were almost
identical to the respective sequences on pIP404. In fact, C.
perfringens F5603 strain was likely to produce a bacteri-
ocin, which was promoted by UV irradiation, using
pCP13-cured strain 13 as an indicator strain. Moreover,
transcription of the bcn5603 gene was likely to be pro-
moted by the addition of mitomycin C (data not shown);
that is, the extreme conservation of the bcn gene cluster
on pBCNF5606 indicates that production of the BCN5603
bacteriocin might be induced in the same manner as for
BCN5 in the CPN50 strain.Comparative genomics using the GenBank database
indicated that bcn5603 gene homologs have been found
in several other virulent strains. These homologs encode
putative bacteriocins that carry commonly conserved do-
mains, namely, SH3 and peptidase M13 family domains.
Moreover, a recent PCR survey indicated that BCN5
gene homologs are found in cpe-positive type A human
disease isolates (F4013 and NCTC8798), as well as type
B, D, and E animal disease isolates [22]. Taking these
findings together, the production of this group of bacte-
riocins by C. perfringens virulent strains might benefit
for them compared with other enteric bacteria in the hu-
man or animal gut, so this group of bacteriocins might
contribute to the virulence of C. perfringens strains.
To date, only two kinds of rep gene have been identi-
fied on C. perfringens plasmids: the rep gene on the anti-
biotic resistance pCW3 plasmid and the rep gene on the
bacteriocin gene-encoding pIP404 [15, 23]. The rep gene
of the most representative toxin gene-encoding plasmids
is highly similar to the rep gene of pCW3 [8, 23]. To
understand the relationship between pBCNF5603 and
other plasmids, especially plasmids carrying the previ-
ously identified rep genes, the replication region of
pBCNF5603 was identified. On the basis of sequence in-
formation for pBCNF5603, a candidate of the putative
replication region, which is similar to the putative
pCP13 plasmid replication region, was identified, while
the rep gene of pCP13 has not yet been identified. The
results of investigating the replication ability of the
PBCN16 region indicated that recombinant plasmids
(pKZ200 and pKZ210), both of which carry PBCN16
and its upstream region, were replicable in two trans-
formable C. perfringens strains, ATCC3624 and strain
13; the similarly organized region of pBCNF5603 with
that of pCP13 is most likely to be the replication region
that must contain the rep gene. Moreover, five inverted
repeated sequences, probably iterons, and an AT-rich re-
gion were also identified upstream of the PBCN16 ORF;
PBCN16 is likely to be the rep gene of pBCNF5603, and
therefore pBCNF5603 might be an iteron-containing plas-
mid (ICP). By comparative genomics using the GenBank
database, PBCN16 homologs were found in several other
plasmids including pCP13, pCP-OS1, and pCP-TS1, which
are toxin-encoding plasmids other than the prototypes of
toxin-encoding plasmid [20]. Moreover, these plasmids
carry upstream iteron-like sequences that are highly simi-
lar to those sequences of PBCN16 (Fig. 3). Therefore, the
plasmid family that carries the PBCN16 homolog in the
putative replication region is also likely to be ICP.
Prototypes of toxin-encoding plasmids carry the com-
mon replication and partitioning system, the parMRC
system, and these systems might be related to plasmid
compatibility [23, 24]. In the same C. perfringens cells of
the F5603 strain, the bacteriocin-encoding plasmid
Miyamoto et al. BMC Microbiology  (2015) 15:118 Page 10 of 12pBCNF5603, which carries a different replication and
partitioning system, the parABS system, can co-exist
with one of the prototypes of toxin-encoding plasmids,
cpe-encoding plasmid pCPF5603. On the other hand, re-
combinant plasmids carrying the identified rep gene and
upstream iteron sequences of pBCNF5603 were likely to
induce pCP13 curing in strain 13; pBCNF5603 and
pCP13 might be incompatible plasmids, possibly because
of iteron-based incompatibility. In general, two compo-
nents, Rep and iterons, lie at the center of all models of
ICP replication control, so replication-mediated incom-
patibility has been used to classify plasmids [7]. Taking
these findings together, pBCNF5603 and pCP13 are likely
to be classified into the same Inc group, but different
groups from the prototypes of toxin-encoding plasmid.
Moreover, on the basis of the high similarity of upstream
iteron sequences of the putative rep gene, recently se-
quenced plasmids, pCP-TS1, pCP-OS1, and other plas-
mids (pF262B and plasmid in WAL-14572 strain), are
likely to belong to the pBCNF5603 Inc family [20, 21].
A recombinant plasmid named pKZ100, which carries
pIP404 rep homolog, PBCN30, is non-functional in C.
perfringens strain, while PBCN30 was also identified as a
candidate of the rep gene on pBCNF5603 by a BLAST
search (Fig. 2b). On the other hand, pIP404 rep gene
homolog on a small plasmid, pCP8533S12, in type B
strain NCTC8533 is functional based on the transform-
ation experiment results obtained using another recom-
binant plasmid, pKZ110. By comparative genomics using
the GenBank database, pIP404 rep gene homologs were
also found in several strains that also harbor prototypes
of toxin-encoding plasmid(s). Comparing the sequence of
these rep homologs in different strains, PBCN30 on
pBCNF5603 was ~200 bp smaller than other homologs; in
addition, PBCN30 on pBCNF5603 has a point mutation
and, as a result, may have become non-functional (Fig. 2b).
From these findings, it was suggested that ~200 bp on the
3’ side of this type of rep gene might be important for plas-
mid replication.
Upstream of the PBCN16 rep gene, the putative plasmid
partitioning-related genes (parA, parB, and maybe PCP03
homolog) and a putative parS sequence were identified
(Fig. 2a). A similarly organized putative partitioning region
was also found on pCP13, pCP-OS1, pCP-TS1, pF262,
and plasmid in the WAL-14572 strain. Therefore, the
highly homologous rep gene (more than 90 % identity)
and a putative partitioning region are likely to be a core
region of these plasmids. In general, the partitioning re-
gion has a central role in plasmid segregation and is thus
important for plasmid stability [25]. To investigate the
contribution of the putative partitioning region of
pBCNF5603 to plasmid stability, the stability of the re-
combinant plasmid that carries the replication and parti-
tioning region was evaluated in two electro-transformablestrains, ATCC3624 and strain 13. Strain 13 originally car-
ries the indigenous plasmid, pCP13, which has a replica-
tion and partitioning region that is closely related to that of
pBCNF5603, while the ATCC3624 strain naturally harbors
no plasmid. Although strain 13 and F5603 strain stably car-
ried pCP13 or pBCNF5603, respectively, the recombinant
plasmid that carries the pBCNF5603-derived replication
and partitioning region was relatively unstable, even in
pCP13-free strain 13-derived strain, as in the ATCC3624
strain. These findings might indicate that the identified
replication and partitioning region of pBCNF5603 is insuf-
ficient for plasmid stability, while the replication and parti-
tioning region is important for plasmid stability [25]. The
possible reasons for recombinant plasmid instability are as
follows: 1) the influence of the integrity of iteron se-
quences and arrangement; 2) the sequence of the genes in
this region might be strictly controlled: the integrity of
these regions might be important for plasmid stability;
and 3) the gene(s) encoding hypothetical or conserved
hypothetical protein on pBCNF5603 could have an im-
portant role in the stability of the plasmid. In addition to
these possibilities, host factors could possibly promote
plasmid stability; the replication and partitioning region
might co-operate with host chromosomal factors [25].
Strain 13 is likely to have a chromosomal genetic back-
ground that is more similar to the F5603 strain than to
the ATCC3624 strain, given previous MLST results [22].
However, the stability levels of the recombinant plasmid
that carries the replication and partitioning region were
very similar in those two C. perfringens strains. Therefore,
the contribution of the host factors to the stability of the
recombinant plasmid could differ compared with plasmids
in E. coli.
Interestingly, a similarly organized putative plasmid par-
titioning region, the parABS region, was found on a β toxin
gene (cpb)-encoding plasmid, pCP8533cbp, in the type B
NCTC8533 strain (accession number: AB736083) (Fig. 2a).
By comparative genomics using the GenBank database,
these conserved parABS regions were also identified on
the cpb plasmids in the type B ATCC3626 strain (accession
number: NZ_ABDV01000024) and in the type C JGS1945
strain (accession number: NZ_ABDU01000064). However,
these cpb-encoding plasmids did not harbor a PCP63
homolog on the upstream region of the parA gene. The
parABS region on these cpb-encoding plasmids could be
related to plasmid properties, such as partitioning element-
based plasmid incompatibility.
To our knowledge, this is the first report about identifi-
cation of the rep gene of a bacteriocin-encoding plasmid
in enterotoxigenic C. perfringens strain. The rep gene
identified in the current study is unique and might be
encoded by important plasmids because the identified rep
gene homologs were found on not only the bacteriocin-
encoding plasmid, but also toxin-encoding plasmids. In
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rep gene or its homolog might be the same Inc family
plasmids.
Conclusions
The current study demonstrated that i) the replication re-
gion of bacteriocin gene encoding plasmid, pBCNF5603
in enterotoxigenic C. perfringens strain was identified, ii)
the plasmid carrying the identified rep gene are predicted
as a iteron-containing plasmid (ICP), iii) the identified
replication region are also found on toxin gene encoding
plasmid in virulent strains, e.g. BEC (binary enterotoxin of
C. perfringens) gene encoding plasmids, iv) the identified
replication region contributes plasmid compatibility; plas-
mids carrying the homologs with the identified rep gene
should belong to the same Inc family, v) the plasmid repli-
cation and the predicted plasmid partitioning regions are
insufficient for stable maintenance of recombinant plas-
mid which carry those of pBCNF5603 in C. perfringens
strains.
Collectively, findings in the current study provide the
important insights of the bacteriocin gene and toxin gene
encoding plasmids in virulent C. perfringens strains; con-
tribution of the replication region to plasmid compatibility
have not been investigated in previous studies, while the
replication region of a few plasmids in virulent C. perfrin-
gens strains was reported. Moreover, role of the plasmid
replication and partitioning regions on C. perfringens plas-
mid stability have not been investigated, although the im-
portant plasmids are likely to be highly stable in virulent
strains. Further detailed studies on the issues investigated
in the current study should help in understanding plasmid
biology in virulent C. perfringens strains.
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